DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Dickson RC, Terrault NA, Ishitani M. et al.
Protective antibody levels and dose requirements for IV 5% Nabi hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease
Liver Transpl 2006; 12: 124-133
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.